Description of Collaborative Activity: |
The purpose of this meeting was to facilitate the advancement of medical countermeasures (MCMs) and biodosimetry devices by assessing the research devices and animal models used in preclinical studies; government policies on reproducibility, rigor and robustness; regulatory considerations for MCMs and biodosimetry devices; and lessons learned from sponsors of early stage MCM or biodosimetry devices. |
